Poxviruses and Lumpy Skin Disease Virus Vaccine

Authors

  • Muhammad Idrees Center for Advanced Studies in Vaccinology and Biotechnology (CASVAB), University of Balochistan, Quetta, Pakistan
  • Abdul Samad Center for Advanced Studies in Vaccinology and Biotechnology (CASVAB), University of Balochistan, Quetta, Pakistan
  • Saad Ullah Jan Center for Advanced Studies in Vaccinology and Biotechnology (CASVAB), University of Balochistan, Quetta, Pakistan
  • Muhammad Naeem Center for Advanced Studies in Vaccinology and Biotechnology (CASVAB), University of Balochistan, Quetta, Pakistan
  • Abdul Samad Livestock and Dairy Development Department, Balochistan, Quetta, Pakistan
  • Adil Khan Department of Biotechnology, Balochistan University of Information Technology, Engineering and Management Sciences, Quetta, Pakistan
  • Palwasha Khan Department of Microbiology, Sardar Bahadur Khan Women’s University (SBKWU), Quetta, Pakistan

DOI:

https://doi.org/10.31580/5m387j42

Keywords:

Ascorbic acid, GC-MS, IC50, RT

Abstract

Poxviruses have very overwhelming effects on the economy. The majority of the poxviruses that cause diseases are animals and birds that contribute their part in the global economy. The very wide host range of poxviruses has played a significant role in disease spread in various species. The Orthopoxviruses are the most widely studied poxviruses because of their dual host range. Different classes of attenuated/inactivated vaccines have been developed to control and eradicate poxvirus diseases. Many vectored vaccines prepared from alternative strains of poxviruses have been licensed to be administered in humans and animals. Different genes of immune-modulation have been discussed that can donate their part of bioterrorism or prevent bioterrorism. In this article, we have reviewed how poxviruses could be of importance in living organisms.

References

Karagoz A, Tombuloglu H, Alsaeed M, Tombuloglu G, AlRubaish AA, Mahmoud A, Smaj-lović S, Ćordić S, Rabaan AA, Alsuhaimi E. Monkeypox (mpox) virus: Classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis. Journal of Infection and Public Health. 2023;16(4):531-541.

Vago C. A new type of insect virus. J. Insect Pathol. 1963;5:275-6.

"Pathogenic Molluscum Contagiosum Virus Sequenced" Antiviral Agents Bulletin: 196–7.August 1996. Retrieved 16 July 2006. (http://www.bioinfo.com/mcv.html).

Ochmann S, Roser M. Smallpox. Our world in data. 2018 Jun 28.

Henderson DA. The eradication of smallpox– an overview of the past, present, and future. Vaccine. 2011;29:D7-9.

Reynolds MG, Holman RC, Yorita Christensen KL, Cheek JE, Damon IK. The incidence of molluscum contagiosum among American Indians and Alaska Natives. PLoS One. 2009;4(4):e5255.

Lennette EH, Halonen P, Murphy FA, Balows A, Hausler WJ, Fenner F, Nakano JH. Poxviri-dae: The Poxviruses. Laboratory Diagnosis of Infectious Diseases Principles and Practice: VOL-UME II Viral, Rickettsial, and Chlamydial Diseases. 1988:177-210.

Fenner F. Studiesin Mousepox (Infectious Ectromelia of Mice) Vii. The Effect of the Age of the Host Upon the Response to Infection. Australian Journal of Experimental Biology & Medical Science. 1949;27(1).

Fenner F. Reactivation of animal viruses. British Medical Journal. 1962;2(5298):135.

Dales S. The uptake and development of vaccinia virus in strain L cells followed with labeled viral deoxyribonucleic acid. The Journal of cell biology. 1963;18(1):51-72.

Buller RM, Palumbo GJ. Poxvirus pathogenesis. Microbiological reviews. 1991 Mar;55(1):80-122.

Lefkowitz EJ, Wang C, Upton C. Poxviruses: past, present and future. Virus research. 2006;117(1):105-18.

Jarullah BA. Incidence of lumpy skin disease among Iraqi cattle in Waset Governorate, Iraq Republic. BA Jarullah Int J Adv Res. 2015;3(4):936-9

Haig DA. Lumpy skin disease. Bull. Epizoot. Dis. Afr. 1957;5(9):421-30..

Chihota CM, Rennie LF, Kitching RP, Mellor PS. Mechanical transmission of lumpy skin dis-ease virus by Aedes aegypti (Diptera: Culicidae). Epidemiology & Infection. 2001;126(2):317-21.

Klement E. Epidemiology and Transmission 13. Lumpy Skin. 2018:53.

Weiss KE. Lumpy skin disease virus. InCytomegaloviruses. Rinderpest Virus. Lumpy Skin Disease Virus 1968 (pp. 111-131). Berlin, Heidelberg: Springer Berlin Heidelberg.

Babiuk S, Bowden TR, Parkyn G, Dalman B, Manning L, Neufeld J, Embury‐Hyatt C, Copps J, Boyle DB. Quantification of lumpy skin disease virus following experimental infection in cat-tle. Transboundary and Emerging diseases. 2008;55(7):299-307

Tuppurainen ES, Babiuk S, Klement E, Tuppurainen ES. Geographic Distribution of Lumpy Skin Disease. Lumpy Skin Disease. 2018:11-3.

Gupta T, Patial V, Bali D, Angaria S, Sharma M, Chahota R. A review: Lumpy skin disease and its emergence in India. Veterinary research communications. 2020;44:111-8.

Haider A, Maryam H, Waqas U, Fatima M, Abbas Z, et al. The Economic Impact of Lumpy Skin Disease and Cost-Effectiveness of Vaccination for the Control of Outbreaks in Pakistan. Vet Med Animal Sci. 2023;6(1): 1125.

Abutarbush SM. Lumpy skin disease (knopvelsiekte, pseudo-urticaria, neethling virus disease, exanthema nodularis bovis).Emerging and re-emerging infectious diseases of livestock. 2017:309-26.

Bížová B, Veselý D, Trojánek M, Rob F. Coinfection of syphilis and monkeypox in HIV posi-tive man in Prague, Czech Republic. Travel medicine and infectious disease. 2022;49:102368.

Duque MP, Ribeiro S, Martins JV, Casaca P, Leite PP, Tavares M, Mansinho K, Duque LM, Fernandes C, Cordeiro R, Borrego MJ. Ongoing monkeypox virus outbreak, Portugal, 29 April to 23 May 2022. Eurosurveillance. 2022 ;27(22):2200424.

Haller SL, Peng C, McFadden G, Rothenburg S. Poxviruses and the evolution of host range and virulence. Infection, Genetics and Evolution. 2014;21:15-40.

Vivancos R, Anderson C, Blomquist P, Balasegaram S, Bell A, Bishop L, Brown CS, Chow Y, Edeghere O, Florence I, Logan S. Community transmission of monkeypox in the United Kingdom, April to May 2022. Eurosurveillance. 2022;27(22):2200422.

Al-Zi'abi O, Nishikawa H, Meyer H. The first outbreak of camelpox in Syria. Journal of Vet-erinary Medical Science. 2007;69(5):541-3.

Gallardo-Romero NF, Aréchiga-Ceballos N, Emerson GL, Martínez-Martínez FO, Doty JB, Nakazawa YJ, Rendón-Franco E, Muñoz-García CI, Villanueva-García C, Ramírez-Cid C, Ga-ma-Campillo LM. Endemic orthopoxvirus circulating in procyonids in Mexico. Journal of wildlife diseases. 2016;52(3):609-15.

Smith SA, Kotwa GJ. Immune response to poxvirus infections in various animals. Critical re-views in microbiology. 2002;28(3):149-85.

Seet BT, Johnston JB, Brunetti CR, Barrett JW, Everett H, Cameron C, Sypula J, Nazarian SH, Lucas A, McFadden G. Poxviruses and immune evasion. Annual review of immunology. 2003;21(1):377-423.

Alcami A, Koszinowski UH. Viral mechanisms of immune evasion. Immunology today. 2000;21(9):447-55.

Bönsch D, Kammer W, Lischke A, Friedrich K. Species-specific agonist/antagonist activities of human interleukin-4 variants suggest distinct ligand binding properties of human and murine common receptor γ chain. Journal of Biological Chemistry. 1995;270(15):8452-7.

Morrison BW, Leder P. A receptor binding domain of mouse interleukin-4 defined by a solid-phase binding assay and in vitro mutagenesis. Journal of Biological Chemistry. 1992;267(17):11957-63.

Chervyakova O, Issabek A, Sultankulova K, Bopi A, Kozhabergenov N, Omarova Z, Tu-lendibayev A, Aubakir N, Orynbayev M. Lumpy skin disease virus with four knocked out genes was attenuated in vivo and protects cattle from infection. Vaccines. 2022;10(10):1705.

Smith VP, Bryant NA, Alcamı A. Ectromelia, vaccinia and cowpox viruses encode secreted interleukin-18-binding proteins. Journal of General Virology. 2000;81(5):1223-30.

Shchelkunov SN, Totmenin AV, Babkin IV, Safronov PF, Ryazankina OI, Petrov NA, Guto-rov VV, Uvarova EA, Mikheev MV, Sisler JR, Esposito JJ. Human monkeypox and smallpox viruses: genomic comparison. FEBS letters. 2001;509(1):66-70.

Gherardi MM, Ramírez JC, Esteban M. IL-12 and IL-18 act in synergy to clear vaccinia virus infection: involvement of innate and adaptive components of the immune system. Journal of General Virology. 2003;84(8):1961-72.

Bernet J, Mullick J, Panse Y, Parab PB, Sahu A. Kinetic analysis of the interactions between vaccinia virus complement control protein and human complement proteins C3b and C4b. Journal of virology. 2004;78(17):9446-57.

Esposito JJ, Sammons SA, Frace AM, Osborne JD, Olsen-Rasmussen M, Zhang M, Govil D, Damon IK, Kline R, Laker M, Li Y. Genome sequence diversity and clues to the evolution of variola (smallpox) virus. Science. 2006;313(5788):807-12.

Perkus ME, Piccini A, Lipinskas BR, Paoletti E. Recombinant vaccinia virus: immunization against multiple pathogens. Science. 1985;229(4717):981-4.

Smith GL, Moss B. Infectious poxvirus vectors have capacity for at least 25 000 base pairs of foreign DNA. Gene. 1983;25(1):21-8.

Yang Z, Bruno DP, Martens CA, Porcella SF, Moss B. Simultaneous high-resolution analysis of vaccinia virus and host cell transcriptomes by deep RNA sequencing. Proceedings of the Na-tional Academy of Sciences. 2010;107(25):11513-8.

Yang Z, Maruri-Avidal L, Sisler J, Stuart CA, Moss B. Cascade regulation of vaccinia virus gene expression is modulated by multistage promoters. Virology. 2013;447(1-2):213-20.

Breitbach CJ, Burke J, Jonker D, Stephenson J, Haas AR, Chow LQ, Nieva J, Hwang TH, Moon A, Patt R, Pelusio A. Intravenous delivery of a multi-mechanistic cancer-targeted onco-lytic poxvirus in humans. Nature. 2011;477(7362):99-102.

Breitbach CJ, Moon A, Burke J, Hwang TH, Kirn DH. A phase 2, open-label, randomized study of Pexa-Vec (JX-594) administered by intratumoral injection in patients with unresectable primary hepatocellular carcinoma. Gene Therapy of Solid Cancers: Methods and Protocols. 2015:343-57.

Rahman MM, McFadden G. Oncolytic virotherapy with myxoma virus. Journal of Clinical Medicine. 2020;9(1):171.

Bublot M, Pritchard N, Swayne DE, Selleck P, Karaca K, Suarez DL, AUDONNET JC, Mickle TR. Development and use of fowlpox vectored vaccines for avian influenza. Annals of the New York Academy of Sciences. 2006t;1081(1):193-201.

Taylor J, Meignier B, Tartaglia J, Languet B, VanderHoeven J, Franchini G, Trimarchi C, Pao-letti E. Biological and immunogenic properties of a canarypox-rabies recombinant, ALVAC-RG (vCP65) in non-avian species. Vaccine. 1995;13(6):539-49.

Minke J, Audonnet JC, Fischer L. Equine viral vaccines: the past, present and future. Veteri-nary Research. 2004;35(4):425-43.

NIIKURA M, NARITA T, MIKAMI T. Establishment and characterization of a thymidine kinase deficient avian fibroblast cell line derived from a Japanese quail cell line, QT35. Journal of Veterinary Medical Science. 1991;53(3):439-46.

Pfeffer M, Meyer H. Poxvirus diagnostics. In Pox viruses 2007 Feb 15 (pp. 355-373). Basel: Birkhäuser Basel.

Czerny CP, Meyer H, Mahnel H. Establishment of an ELISA for the detection of orthopox viruses based on neutralizing monoclonal and polyclonal antibodies. Journal of Veterinary Medi-cine, Series B. 1989;36(1‐10):537-46.

Heine HG, Stevens MP, Foord AJ, Boyle DB. A capripoxvirus detection PCR and antibody ELISA based on the major antigen P32, the homolog of the vaccinia virus H3L gene. Journal of immunological methods. 1999 ;227(1-2):187-96.

Gubser C, Hué S, Kellam P, Smith GL. Poxvirus genomes: a phylogenetic analysis. Journal of General Virology. 2004;85(1):105-17.

Carn VM. An antigen trapping ELISA for the detection of capripoxvirus in tissue culture su-pernatant and biopsy samples. Journal of Virological methods. 1995;51(1):95-102.

Heine HG, Stevens MP, Foord AJ, Boyle DB. A capripoxvirus detection PCR and antibody ELISA based on the major antigen P32, the homolog of the vaccinia virus H3L gene. Journal of immunological methods. 1999;227(1-2):187-96.

Mahnel H. Experimental results of the stability of poxviruses under laboratory and environ-mental conditions. Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B. 1987;34(6):449-64.

Noda M, Matsuda S, Kobayashi M. Virucidal activity of disinfectants. Influence of the serum protein upon the virucidal activity of disinfectants. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases. 2000;74(8):664-9.

Weber DJ, Barbee SL, Sobsey MD, Rutala WA. The effect of blood on the antiviral activity of sodium hypochlorite, a phenolic, and a quaternary ammonium compound. Infection Control & Hospital Epidemiology. 1999;20(12):821-7.

Rheinbaben FV, Gebel J, Exner M, Schmidt A. Environmental resistance, disinfection, and sterilization of poxviruses. Poxviruses. 2007;397-405.

McKeegan KS, Borges-Walmsley MI, Walmsley AR. Microbial and viral drug resistance mechanisms. Trends in microbiology. 2002;10(10):s8-14.

Sánchez-Sampedro L, Perdiguero B, Mejías-Pérez E, García-Arriaza J, Di Pilato M, Esteban M. The evolution of poxvirus vaccines. Viruses. 2015;7(4):1726-803.

Artenstein AW, Johnson C, Marbury TC, Morrison D, Blum PS, Kemp T, Nichols R, Balser JP, Currie M, Monath TP. A novel, cell culture-derived smallpox vaccine in vaccinia-naive adults. Vaccine. 2005;23(25):3301-9.

Drexler I, Staib C, Sutter G. Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?. Current opinion in biotechnology. 2004;15(6):506-12.

Drexler I, Staib C, Kastenmüller W, Stevanović S, Schmidt B, Lemonnier FA, Rammensee HG, Busch DH, Bernhard H, Erfle V, Sutter G. Identification of vaccinia virus epitope-specific HLA-A* 0201-restricted T cells and comparative analysis of smallpox vaccines. Proceedings of the National Academy of Sciences. 2003;100(1):217-22.

Werner GT, Jentzsch U, Metzger E, Simon J. Studies on poxvirus infections in irradiated ani-mals. Archives of Virology. 1980; 64:247-56.

67 Bhanuprakash V, Hosamani M, Venkatesan G, Balamurugan V, Yogisharadhya R, Singh RK. Animal poxvirus vaccines: a comprehensive review. Expert review of vaccines. 2012;11 (11):1355-74.

68 Carn VM, Timms CP, Chand P, Black DN, Kitching RP. Protection of goats against capripox using a subunit vaccine. Veterinary record. 1994;135 (18):434-6.

69 Ngichabe CK, Wamwayi HM, Ndungu EK, Mirangi PK, Bostock CJ, Black DN, Barrett T. Long term immunity in African cattle vaccinated with a recombinant capripox-rinderpest virus vaccine. Epidemiology & Infection. 2002;128(2):343-9.

70 Aspden K, van Dijk AA, Bingham J, Cox D, Passmore JA, Williamson AL. Immunogenicity of a recombinant lumpy skin disease virus (neethling vaccine strain) expressing the rabies virus glycoprotein in cattle. Vaccine. 2002;20(21-22):2693-701.

Downloads

Published

2023-11-21